Start and Duration. 14.1. The Production Phase shall begin on the date of submission of the Declaration of Commercial Feasibility and shall last only while this Agreement is effective.
Start and Duration. 9.1. The Production Phase of each Development Area shall begin on the date of submission of the Declaration of Commercial Feasibility and shall last for twenty-seven (27) years.
Start and Duration. This Agreement is effective as of the date of execution and shall remain valid and in force until the CLINICAL TRIAL has been fully completed, without prejudice to the provisions of Clause NINE. To such effects, the CLINICAL TRIAL shall only been considered as fully completed upon due execution by each Party of their respective obligations of this Agreement.
Start and Duration. The Production Phase of each Development Area shall begin on the date of submission of the Declaration of Commercial Feasibility and shall last for twenty-seven (27) years. The provisions of this Section regarding extension or termination of this Agreement apply to each Development Area or Field, on an individual basis. Extension at the Concessionaire’s request The Concessionaire may apply for extension of the term provided for in paragraph 9.1 upon submission of a request to ANP, together with a reviewed Development Plan, at least twenty-four (24) months before the end of such term. ANP shall answer the request for review of the Development Plan and extension of the Production Phase within no more than one hundred and eighty (180) days, and it may refuse the Concessionaire’s proposal or subject it to changes in the reviewed Development Plan, as long as justified. Extension by determination of ANP ANP may request the Concessionaire to proceed with the Field Operation upon a minimum two hundred seventy (270)-day notice of the expected end of the Production. ANP’s request may be refused only upon justification based on evidenced non-cost-effectiveness, among other reasons. In case of refusal by the Concessionaire, ANP shall have sixty (60) days of receipt of the justification to analyze the arguments presented and resolve upon the matter. After ninety (90) days of ANP’s proposal, the absence of the Concessionaire’s reply shall be deemed implied acceptance. The Agreement shall be extended for the additional time indicated by ANP. Consequence of the Extension If case of extension of the Production Phase, under paragraphs 9.3 or 9.4, the Parties shall remain bound by the exact terms and conditions of this Agreement, except for, exclusively, any amendments agreed due to and for the purposes of such extension. At the end of the Production Phase, paragraphs 9.3 or 9.4 shall apply for the purposes of a possible new extension, as appropriate.
Start and Duration. 5.1. The Exploration Phase shall have the duration set forth in Annex II and shall consist of a single period.
Start and Duration. The TRIAL will not be initiated unless the mandatory permission of the Spanish Agency for Drugs and Health Products (“Agencia Española de Medicamentos y Productos Sanitarios”, AEMPS, from now on) has been issued. The parties commit themselves to make sure that the TRIAL is conducted as specified by the PROTOCOL, and specifically, not to start the TRIAL without the permission of the AEMPS. The estimated duration of the TRIAL is ________ months from the date of the AEMPS permission, as indicated in the protocol. In case of competitive recruitment, the number of the recruited subjects may differ from the number originally planned.
Start and Duration. 8.1. The Production Phase of the Field shall begin on the date of submission of the Declaration of Commercial Feasibility and shall last for fifteen (15) years.
Start and Duration. The STUDY will not be initiated unless the mandatory permissions, the favourable opinion of the local Ethic Committee, the Site Management Agreement, and any other authorization that is required by the Legislation of applicable Regulation has been issued The suitability of the present contract is subject to obtaining the referred authorizations. The parties commit themselves to make sure that the STUDY is conducted as specified by the PROTOCOL, and specifically, not to start the STUDY without all mandatory permissions. The estimated duration of the STUDY is eight months from the date of the contract signature, as indicated in the protocol. In case of competitive recruitment, the number of the recruited subjects may differ from the number originally planned.
Start and Duration. This Agreement is effective as of the date of execution and shall remain valid and in force until the CLINICAL TRIAL has been fully completed, without prejudice to the provisions of CLAUSE TEN. To such effect, the CLINICAL TRIAL shall only beconsidered as fully completed upon due execution by each Party of their respective obligations of this Agreement. The CLINICAL TRIAL shall not be initiated unless and until the mandatory permission of the Spanish Agency for Drugs and Health Products (‘Agencia Española de Medicamentos y ProductosSanitarios’) (hereinafter AEMPS) has been obtained in the terms provided by Royal Decree 1090/2015, and also until the authorisations of both the competent CREC, and any other, if any, required by the laws have been obtained. The effectiveness of this Agreement, with protocol version ……….... of date ………….. is subject to the authorisations above being obtained in due course. The Parties acknowledge that each of them is responsible for the execution of the CLINICAL TRIAL exactly as per the specifications contained in the PROTOCOL. The estimated duration of the CLINICAL TRIAL is …….... month(s), as specified in the PROTOCOL.
